ClinicalTrials.Veeva

Menu

Improving Knowledge in Heart Failure Inpatient With Therapeutic Education (EDUC-IC)

University Hospitals (UH) logo

University Hospitals (UH)

Status

Terminated

Conditions

Medication Adherence
Pharmacist-Patient Relations
Heart Failure; With Decompensation
Heart Failure With Reduced Ejection Fraction
Knowledge, Attitudes, Practice

Treatments

Other: Patient therapeutic education

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05751772
2022-00731

Details and patient eligibility

About

The objective is to evaluate the impact of a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients. The knowledge score on heart failure disease and medications will be compared between two groups one month after hospitalization. The intervention group will receive a therapeutic education intervention and usual hospital care and the control group will receive only usual hospital care.

Full description

Heart failure patients are at risk of decompensation of their disease and frequent hospitalizations. Poor adherence to their treatment may be the cause. By improving the knowledge of hospitalized heart failure patients about their disease and their medications, it is expected that these patients will adhere better to their heart failure drug therapy and benefit from a better effectiveness of their treatment. This could promote an improvement in their quality of life, a decrease in their risk of disease complications and even an increase in their life expectancy.

The objective of this research project is to deploy a therapeutic teaching intervention at the bedside of decompensated and hospitalized heart failure patients, associated with follow-up by the pharmacist at discharge from the hospital, and to measure its impact on knowledge change (primary endpoint), on their beliefs about medications, on their therapeutic adherence, and on the consumption of unplanned care such as rehospitalizations and emergency room visits (secondary endpoints).

Enrollment

38 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Hospitalization in the Department of General Internal Medicine or Cardiology for decompensated heart failure with lowered left ventricular ejection fraction (LVEF) (≤40%) from any cause or mildly lowered LVEF (41-49%) with the presence of heart failure-specific drug therapy
  • Stability of the patient's clinical condition
  • ≥ 2 heart failure medications
  • ≥18 years
  • Full capacity of discernment
  • Absence of cognitive impairment
  • Ability to speak, understand and read in French
  • Get a personal telephone
  • Consent form signed by the participant

Exclusion criteria

  • Inability to follow study procedures
  • Institutionalized persons
  • Asylum seekers, homeless people, prisoners
  • Incapacity of judgment and discernment

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

38 participants in 2 patient groups

"Patient therapeutic education" group
Experimental group
Description:
The intervention group will benefit from a pharmacist-led therapeutic education intervention on the knowledge of hospitalized heart failure patients and usual hospital care (medical and nursing care)
Treatment:
Other: Patient therapeutic education
"Usual hospital care" group
No Intervention group
Description:
The control group do only benefit from the usual hospital care (any medical and nursing care giving to an acute heart failure inpatient) and won't benefit from the pharmacist's educational intervention.

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Mégane Jermini, pharmD; Pascal Bonnabry, Professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems